Moderna (MRNA) Non-Current Assets (2017 - 2025)
Historic Non-Current Assets for Moderna (MRNA) over the last 9 years, with Q3 2025 value amounting to $5.5 billion.
- Moderna's Non-Current Assets fell 977.68% to $5.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $23.4 billion, marking a year-over-year decrease of 1471.19%. This contributed to the annual value of $6.0 billion for FY2024, which is 2540.43% down from last year.
- Per Moderna's latest filing, its Non-Current Assets stood at $5.5 billion for Q3 2025, which was down 977.68% from $5.8 billion recorded in Q2 2025.
- In the past 5 years, Moderna's Non-Current Assets registered a high of $12.5 billion during Q2 2022, and its lowest value of $991.0 million during Q1 2021.
- Moreover, its 5-year median value for Non-Current Assets was $7.5 billion (2021), whereas its average is $8.0 billion.
- In the last 5 years, Moderna's Non-Current Assets skyrocketed by 103612.51% in 2022 and then plummeted by 4666.37% in 2024.
- Quarter analysis of 5 years shows Moderna's Non-Current Assets stood at $8.6 billion in 2021, then skyrocketed by 44.53% to $12.4 billion in 2022, then plummeted by 34.81% to $8.1 billion in 2023, then fell by 25.4% to $6.0 billion in 2024, then fell by 8.37% to $5.5 billion in 2025.
- Its Non-Current Assets was $5.5 billion in Q3 2025, compared to $5.8 billion in Q2 2025 and $5.9 billion in Q1 2025.